Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayajit Das

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Clonal stochasticity in early NK cell response to mouse cytomegalovirus is generated by mature subsets of varying proliferative abilityDarren Wethington, Saeed Ahmad, Marc Potempa, et al.
Nature Nanotechnology|July 1, 2020
Role of nanoscale antigen organization on B-cell activation probed using DNA origamiRémi Veneziano, Tyson J Moyer, Matthew B Stone, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2026
A framework integrating multiscale in silico modeling and experimental data predicts CAR-NK cell cytotoxicity across target cell typesSaeed Ahmad, Kun Xing, Marcelo S F Pereira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacyAlberto J Millan, Vincent Allain, Indrani Nayak, et al.
Science Advances|August 23, 2024
The nuclear export protein XPO1 provides a peptide ligand for natural killer cellsMatthew D Blunt, Hayden Fisher, Ralf B Schittenhelm, et al.
Journal for Immunotherapy of Cancer|September 12, 2022
Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8<sup>+</sup> T cell antitumor immunityAnqi Li, Yuzhou Chang, No-Joon Song, et al.
Cancer Discovery|June 18, 2025
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint BlockersNo-Joon Song, Juan Xie, Kyeong Joo Jung, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Clonal stochasticity in early NK cell response to mouse cytomegalovirus is generated by mature subsets of varying proliferative abilityDarren Wethington, Saeed Ahmad, Marc Potempa, et al.
Nature Nanotechnology|July 1, 2020
Role of nanoscale antigen organization on B-cell activation probed using DNA origamiRémi Veneziano, Tyson J Moyer, Matthew B Stone, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2026
A framework integrating multiscale in silico modeling and experimental data predicts CAR-NK cell cytotoxicity across target cell typesSaeed Ahmad, Kun Xing, Marcelo S F Pereira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacyAlberto J Millan, Vincent Allain, Indrani Nayak, et al.
Science Advances|August 23, 2024
The nuclear export protein XPO1 provides a peptide ligand for natural killer cellsMatthew D Blunt, Hayden Fisher, Ralf B Schittenhelm, et al.
Journal for Immunotherapy of Cancer|September 12, 2022
Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8<sup>+</sup> T cell antitumor immunityAnqi Li, Yuzhou Chang, No-Joon Song, et al.
Cancer Discovery|June 18, 2025
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint BlockersNo-Joon Song, Juan Xie, Kyeong Joo Jung, et al.
Pageof 7